CAS 1831110-54-3

MS023

Description:

MS023, identified by its CAS number 1831110-54-3, is a chemical compound that has garnered interest in the field of medicinal chemistry, particularly for its potential applications in cancer research. It is characterized as a selective inhibitor of certain protein kinases, which play crucial roles in cell signaling pathways that regulate cell growth and proliferation. The compound exhibits a specific mechanism of action that allows it to interfere with the activity of target kinases, thereby influencing cellular processes. MS023 is typically studied in vitro and in vivo to evaluate its efficacy and safety profile, as well as its pharmacokinetic properties. Its chemical structure includes functional groups that contribute to its biological activity and solubility. As research continues, MS023 may provide insights into novel therapeutic strategies for treating various malignancies, highlighting the importance of targeted therapies in oncology. However, detailed studies are necessary to fully understand its potential benefits and limitations in clinical applications.

Formula: C₁₇H₂₅N₃O

Synonyms:

• MS023
• N1-Methyl-N1-[[4-[4-(1-methylethoxy)phenyl]-1H-pyrrol-3-yl]methyl]-1,2-ethanediamine

1,2-Ethanediamine, N1-methyl-N1-[[4-[4-(1-methylethoxy)phenyl]-1H-pyrrol-3-yl]methyl]-

CAS: 1831110-54-3

Formula: C₁₇H₂₅N₃O

Purity: 98%

Color and Shape: Solid

Molecular weight: 287.3999

Ref: IN-DA0024DU

MS023

CAS: 1831110-54-3

MS023

Purity: ≥98%

Molecular weight: 287.4g/mol

Ref: 54-BUP12273

MS023

CAS: 1831110-54-3

Formula: C₁₇H₂₅N₃O

Molecular weight: 287.41

Ref: 4Z-K-031012

MS023

CAS: 1831110-54-3

MS023 is a potent, selective, and cell-active Type I PRMT inhibitor with IC50 of 30 nM, 119 nM, 83 nM, 4 nM, and 5 nM for PRMT1, PRMT3, PRMT4, PRMT6 and PRMT8,

Formula: C₁₇H₂₅N₃O

Purity: 98.31% - 99.87%

Color and Shape: Solid

Molecular weight: 287.4

Ref: TM-T6900

1,2-Ethanediamine, N1-methyl-N1-[[4-[4-(1-methylethoxy)phenyl]-1H-pyrrol-3-yl]methyl]-

CAS: 1831110-54-3

Purity: 98%

Molecular weight: 287.4070129

Ref: 10-F862069

MS023

CAS: 1831110-54-3

Methyltransferase (MT) inhibitors are a class of compounds that inhibit the transfer of methyl groups to specific substrates. MS023 is a novel MT inhibitor that has been shown to be clinically relevant for treating prostate cancer cells and hematopoietic cells. It inhibits the activity of MT enzymes in these cells by binding to the active site of the enzyme. The stability of this complex is determined by the protein-protein interactions between MS023 and MT. These interactions stabilize the complex, which prevents it from dissociating from MT, making it more difficult for MT to bind with its substrate.
MS023 has also been shown to have antiviral properties in vitro. It was able to inhibit viral life cycles and polymerase chain reactions (PCR) with stable complexes formed with dna methyltransferases (DNMT). This makes MS023 an attractive compound as a treatment for human immunodeficiency virus type 1 (HIV-1) infection, which causes AIDS.

Formula: C₁₇H₂₅N₃O

Purity: Min. 95%

Molecular weight: 287.4 g/mol

Ref: 3D-GYC11054